 |
|
Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture
J. Brent Richards, MD;
Alexandra Papaioannou, MD, MSc;
Jonathan D. Adachi, MD;
Lawrence Joseph, PhD;
Heather E. Whitson, MD;
Jerilynn C. Prior, MD;
David Goltzman, MD; for the Canadian Multicentre Osteoporosis Study (CaMos) Research Group
Arch Intern Med. 2007;167(2):188-194.
Background Depression and osteoporotic fractures are common ailments among elderly persons. Selective serotonin reuptake inhibitors (SSRIs) are frequently used in the treatment of depression in this population, and the association between daily SSRI use and fragility fractures is unclear. Our objective was to examine the effect of daily SSRI use on the risk of incident clinical fragility fracture.
Methods A population-based, randomly selected, prospective cohort study of 5008 community-dwelling adults 50 years and older, followed up over 5 years for incident fractures. Clinical fragility fractures were classified as minimal trauma fractures that were clinically reported and radiographically confirmed. The risk of fragility fracture associated with daily SSRI use was determined while controlling for relevant covariates.
Results Daily SSRI use was reported by 137 subjects. After adjustment for many potential covariates, daily SSRI use was associated with substantially increased risk of incident clinical fragility fracture (hazard rate, 2.1; 95% confidence interval, 1.3-3.4). Daily SSRI use was also associated with increased odds of falling (odds ratio, 2.2; 95% confidence interval, 1.4-3.5), lower bone mineral density at the hip, and a trend toward lower bone mineral density at the spine. These effects were dose dependent and were similar for those who reported taking SSRIs at baseline and at 5 years' follow-up.
Conclusions Daily SSRI use in adults 50 years and older remained associated with a 2-fold increased risk of clinical fragility fracture after adjustment for potential covariates. Depression and fragility fractures are common in this age group, and the elevated risk attributed to daily SSRI use may have important public health consequences.
Author Affiliations: Division of Endocrinology and Metabolism, Department of Medicine (Drs Richards and Goltzman), and Department of Epidemiology and Biostatistics (Drs Richards and Joseph), McGill University, and Bone and Calcium Research Laboratories, Royal Victoria Hospital (Dr Goltzman), Montreal, Quebec; Division of Geriatric Medicine, Department of Medicine, Hamilton Health Sciences (Dr Papaioannou), and Department of Medicine, St Joseph's Healthcare (Dr Adachi), McMaster University, Hamilton, Ontario; Department of Endocrinology and Medicine, University of British Columbia, Vancouver (Dr Prior); Division of Geriatrics, Department of Medicine, Duke University School of Medicine, Durham, NC (Dr Whitson).
RELATED LETTERS
Selective Serotonin Reuptake Inhibitors and Risk of Fracture in Elderly Persons
Oladipo Kukoyi
Arch Intern Med. 2007;167(21):2369.
EXTRACT
| FULL TEXT
Association Between SSRI Use and Fractures and the Effect of Confounding by Indication
Gijsbertus Ziere, Jeanne P. Dieleman, Tischa J. M. van der Cammen, and Bruno H. Ch. Stricker
Arch Intern Med. 2007;167(21):2369-2370.
EXTRACT
| FULL TEXT
A Possible Role of Recurrent Major Depression in Risk of Fracture
Sinead M. O’Brien
Arch Intern Med. 2007;167(21):2370.
EXTRACT
| FULL TEXT
A Possible Role of Recurrent Major Depression in Risk of Fracture—Reply
J. Brent Richards, Alexandra Papaioannou, Jonathan D. Adachi, Lawrence Joseph, Heather E. Whitson, Jerilynn C. Prior, David Goltzman, and for the CaMos Research Group
Arch Intern Med. 2007;167(21):2370-2371.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Efficacy of Second Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the Evidence
Nelson et al.
AJGP 2008;16:558-567.
ABSTRACT
| FULL TEXT
SSRIs and Osteoporosis
Obstet Gynecol 2008;111:1207-1208.
FULL TEXT
Low Bone Mass in Premenopausal Women With Depression
Eskandari et al.
Arch Intern Med 2007;167:2329-2336.
ABSTRACT
| FULL TEXT
Selective Serotonin Reuptake Inhibitors and Risk of Fracture in Elderly Persons
Kukoyi
Arch Intern Med 2007;167:2369-2369.
FULL TEXT
A Possible Role of Recurrent Major Depression in Risk of Fracture
O'Brien
Arch Intern Med 2007;167:2370-2370.
FULL TEXT
Association Between SSRI Use and Fractures and the Effect of Confounding by Indication
Ziere et al.
Arch Intern Med 2007;167:2369-2370.
FULL TEXT
A Possible Role of Recurrent Major Depression in Risk of Fracture Reply
Richards et al.
Arch Intern Med 2007;167:2370-2371.
FULL TEXT
Mend the Mind, but Mind the Bones!: Balancing Benefits and Potential Skeletal Risks of Serotonin Reuptake Inhibitors
Saag
Arch Intern Med 2007;167:1231-1232.
FULL TEXT
Patient Assessment in the Diagnosis, Prevention, and Treatment of Osteoporosis
Lata and Elliott
Nutr Clin Pract 2007;22:261-275.
ABSTRACT
| FULL TEXT
SSRIs Increase Fracture Risk in Older Women
JWatch Women's Health 2007;2007:1-1.
FULL TEXT
SSRIs and Medical Illness: The Good and the Bad
JWatch Psychiatry 2007;2007:1-1.
FULL TEXT
|
